Release is launching a vital initiative. We are launching the #ReleaseOurMeds campaign to protect the rights of patients to access
Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive
Achievement allows manufacturing of pharmaceutical grade Cannabis flower addressed to international markets. The accreditation assures patients, healthcare professionals, and regulatory
An online crowdfunder has been launched to raise funds to kickstart a key campaign to generate awareness of prescription cannabis
High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver
Curaleaf International, part of Curaleaf Holdings (TSX:CURA) and one of Europe’s largest vertically integrated cannabis companies, is expanding into the
The birth of a vertically integrated, EU GMP, Clean Green(R) certified organic, global medical cannabis company with a unique and
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines SOMAÍ Pharmaceuticals (“SOMAÍ”), an
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance. Exclusive partnership with some
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.